These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 11313866

  • 1. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
    Sugibayashi R, Shimizu T, Suzuki T, Yamamoto N, Hamada H, Takeda K.
    Oncogene; 2001 Mar 08; 20(10):1220-8. PubMed ID: 11313866
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R, Kiguchi Y, Shimizu T, Suzuki T, Hamada H, Takeda K.
    Anticancer Res; 2002 Mar 08; 22(2A):713-9. PubMed ID: 12014641
    [Abstract] [Full Text] [Related]

  • 3. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
    Lin SY, Liang YC, Ho YS, Tsai SH, Pan S, Lee WS.
    Mol Carcinog; 2002 Sep 08; 35(1):21-8. PubMed ID: 12203364
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of genes during TPA-induced differentiation of human prostatic cancer TSU-Pr1 cells.
    Suzuki T, Shimizu T, Satoh K, Sugibayashi R, Takeda K.
    Int J Mol Med; 2002 Dec 08; 10(6):735-9. PubMed ID: 12430000
    [Abstract] [Full Text] [Related]

  • 5. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
    Salabat MR, Ding XZ, Flesche JB, Ujiki MB, Robin TP, Talamonti MS, Bell RH, Adrian TE.
    Pancreas; 2006 Aug 08; 33(2):148-55. PubMed ID: 16868480
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines.
    Ullmannová V, Stöckbauer P, Hradcová M, Soucek J, Haskovec C.
    Leuk Res; 2003 Dec 08; 27(12):1115-23. PubMed ID: 12921950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
    Yan S, Wenner CE.
    J Cell Physiol; 2001 Mar 22; 186(3):338-49. PubMed ID: 11169972
    [Abstract] [Full Text] [Related]

  • 13. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K, Shirasawa S, Nishioka M, Sasazuki T.
    Cancer Res; 1999 May 15; 59(10):2445-50. PubMed ID: 10344756
    [Abstract] [Full Text] [Related]

  • 14. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W.
    Cancer Lett; 2006 Jul 28; 239(1):27-35. PubMed ID: 16169661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.